European Medical Journal

IgG-Targeted Treatment for CIDP: Real-World Evidence on Transitioning from IVIg to Guide Clinical Practice

Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare and severe immune-mediated disease that affects sensory ...
Everyday Health

Making the Switch: Moving From IVIg to SCIg for CIDP

Treatment for chronic inflammatory demyelinating polyneuropathy (CIDP) includes IV infusion at a medical clinic, but now you can get a similar treatment through an injection or infusion at home.
Nature

Effect of Intravenous Immunoglobulin (IVIG) Supplementation on infection-free survival in recipients of BCMA-directed bispecific antibody therapy for multiple myeloma

B-cell maturation antigen (BCMA) targeting bispecific antibodies (bsAb) for multiple myeloma (MM) have shown unprecedented clinical efficacy in patients with relapsed refractory disease [1,2,3,4].
technologynetworks

Intravenous Immunoglobulin Alternative Therapy Achieves Equal Effect at 1% Dose

Intravenous immunoglobulin (IVIG) therapy involves infusing patients with naturally occurring IgG antibodies to treat autoimmune conditions. With origins dating back to the 1950s, IVIG is currently ...
The American Journal of Managed Care

IVIG Shows Promise in Protecting Older Patients With Lymphoma From COVID-19

Prophylactic intravenous immunoglobulin reduces COVID-19 infection rates in older patients with DLBCL with hypogammaglobulinemia undergoing reduced-intensity R-CHOP therapy. The study, conducted ...
Nature

Neutrophil percentage-to-albumin ratio is a potential marker of intravenous immunoglobulin resistance in Kawasaki disease

Intravenous immunoglobulin (IVIG) resistance in Kawasaki disease (KD) was associated with coronary artery lesions. Neutrophil percentage-to-albumin ratio (NPAR) is an index of mortality in several ...